|
🐜
|
Increased periostin associates with greater airflow limitation in patients receiving inhaled corticosteroids.
31 auth.
Y. Kanemitsu,
H. Matsumoto,
K. Izuhara,
Y. Tohda,
H. Kita,
T. Horiguchi,
K. Kuwabara,
K. Tomii,
K. Otsuka,
M. Fujimura,
N. Ohkura,
K. Tomita,
A. Yokoyama,
H. Ohnishi,
Y. Nakano,
...
T. Oguma,
S. Hozawa,
T. Nagasaki,
I. Ito,
T. Oguma,
H. Inoue,
T. Tajiri,
T. Iwata,
Y. Izuhara,
J. Ono,
S. Ohta,
M. Tamari,
T. Hirota,
T. Yokoyama,
A. Niimi,
M. Mishima
|
7 |
2013 |
7
🐜
|
|
🐜
|
Comprehensive efficacy of omalizumab for severe refractory asthma: a time-series observational study.
14 auth.
T. Tajiri,
A. Niimi,
H. Matsumoto,
I. Ito,
T. Oguma,
K. Otsuka,
T. Takeda,
Hitoshi Nakaji,
H. Inoue,
T. Iwata,
...
T. Nagasaki,
Y. Kanemitsu,
Y. Izuhara,
M. Mishima
|
6 |
2014 |
6
🐜
|
|
🐜
|
Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with chronic obstructive pulmonary disease.
12 auth.
K. Hirai,
A. Tanaka,
T. Homma,
Y. Goto,
K. Akimoto,
Tomoki Uno,
...
Uchida Yoshitaka,
Y. Miyata,
H. Inoue,
S. Ohta,
S. Suzuki,
H. Sagara
|
6 |
2020 |
6
🐜
|
|
🐜
|
Utility of serum periostin and free IgE levels in evaluating responsiveness to omalizumab in patients with severe asthma
19 auth.
T. Tajiri,
H. Matsumoto,
Yasuhiro Gon,
Reiko Ito,
Shu Hashimoto,
K. Izuhara,
M. Suzukawa,
K. Ohta,
J. Ono,
S. Ohta,
...
I. Ito,
T. Oguma,
H. Inoue,
T. Iwata,
Y. Kanemitsu,
T. Nagasaki,
A. Niimi,
A. Niimi,
M. Mishima
|
6 |
2016 |
6
🐜
|
|
🐜
|
Gastroesophageal dysmotility is associated with the impairment of cough-specific quality of life in patients with cough variant asthma.
13 auth.
Y. Kanemitsu,
A. Niimi,
H. Matsumoto,
T. Iwata,
I. Ito,
T. Oguma,
H. Inoue,
T. Tajiri,
T. Nagasaki,
Y. Izuhara,
...
G. Petrova,
S. Birring,
M. Mishima
|
5 |
2016 |
5
🐜
|
|
🐜
|
Integrating longitudinal information on pulmonary function and inflammation using asthma phenotypes.
29 auth.
T. Nagasaki,
H. Matsumoto,
Y. Kanemitsu,
K. Izuhara,
Y. Tohda,
H. Kita,
T. Horiguchi,
K. Kuwabara,
K. Tomii,
K. Otsuka,
M. Fujimura,
N. Ohkura,
K. Tomita,
A. Yokoyama,
H. Ohnishi,
...
Y. Nakano,
T. Oguma,
S. Hozawa,
I. Ito,
T. Oguma,
H. Inoue,
T. Tajiri,
T. Iwata,
Y. Izuhara,
J. Ono,
S. Ohta,
T. Yokoyama,
A. Niimi,
M. Mishima
|
5 |
2014 |
5
🐜
|
|
🐜
|
Association of Alveolar Nitric Oxide Levels with Pulmonary Function and Its Reversibility in Stable Asthma
14 auth.
H. Matsumoto,
A. Niimi,
M. Jinnai,
Hitoshi Nakaji,
T. Takeda,
T. Oguma,
K. Otsuka,
H. Inoue,
M. Yamaguchi,
H. Matsuoka,
...
I. Ito,
T. Hirai,
K. Chin,
M. Mishima
|
5 |
2010 |
5
🐜
|
|
🐜
|
Smoking attenuates the age‐related decrease in IgE levels and maintains eosinophilic inflammation
13 auth.
T. Nagasaki,
H. Matsumoto,
Hitoshi Nakaji,
A. Niimi,
A. Niimi,
I. Ito,
T. Oguma,
S. Muro,
H. Inoue,
T. Iwata,
...
T. Tajiri,
Y. Kanemitsu,
M. Mishima
|
5 |
2012 |
5
🐜
|
|
🐜
|
GLCCI1 variant accelerates pulmonary function decline in patients with asthma receiving inhaled corticosteroids
31 auth.
Y. Izuhara,
H. Matsumoto,
Y. Kanemitsu,
K. Izuhara,
Y. Tohda,
T. Horiguchi,
H. Kita,
K. Kuwabara,
K. Tomii,
K. Otsuka,
M. Fujimura,
N. Ohkura,
K. Tomita,
A. Yokoyama,
H. Ohnishi,
...
Y. Nakano,
T. Oguma,
S. Hozawa,
T. Nagasaki,
I. Ito,
T. Oguma,
H. Inoue,
T. Tajiri,
T. Iwata,
J. Ono,
S. Ohta,
M. Tamari,
T. Hirota,
T. Yokoyama,
A. Niimi,
M. Mishima
|
5 |
2014 |
5
🐜
|
